Corrigendum: Case report: Challenges in the diagnosis of a case of Mal de Meleda and a therapeutic attempt of ixekizumab and Adalimumab

Yuwei Dai,Xiaodong Zheng,Qi Zhang,Xia Hu,Peiguang Wang,Sen Yang

DOI: https://doi.org/10.3389/fmed.2022.1106530

IF: 3.9

2022-12-12

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.821301.].

medicine, general & internal

What problem does this paper attempt to address?

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Lijun Du,Jinhua Shen,John J. Kim,Yunxian Yu,Lu Ma,Ning Dai

DOI: https://doi.org/10.1038/srep46121

IF: 4.6

2017-01-01

Scientific Reports

Abstract:Scientific Reports 6: Article number: 34305; published online: 06 October 2016; updated: 07 April 2017 Affiliation 1 was incorrectly listed as ‘Department of Gastroenterology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang province 310016, China’ in the original version of the Article.
Case Report: Challenges in the Diagnosis of a Case of Mal de Meleda and a Therapeutic Attempt of Ixekizumab and Adalimumab

Yuwei Dai,Xiaodong Zheng,Qi Zhang,Xia Hu,Peiguang Wang,Sen Yang

DOI: https://doi.org/10.3389/fmed.2022.821301

IF: 3.9

2022-03-10

Frontiers in Medicine

Abstract:Background Mal de Meleda (MDM, OMIM 248300) is an autosomal recessive disease characterized by symmetrical and progressive palmoplantar hyperkeratosis soon after birth. Mutations in SLURP1 gene could lead to MDM. Clinically, MDM is easily misdiagnosed as other types of keratoderma due to phenotypic variation and overlap. Objective and Methods A patient with suspected MDM was confirmed by the combination of next-generation sequencing and Exomiser, and the patient was attempted with the treatment of Ixekizumab and Adalimumab. Results A homozygous mutation c.256G>A (p.Gly86Arg) in the SLURP1 gene was identified in the patient. The inflammatory erythemas on his hands, feet and buttocks were mildly relieved after the treatment of high dose of Ixekizumab. Conclusions Our findings helps to enhance the understanding of MDM. Ixekizumab may be a potential strategy to treat MDM.

medicine, general & internal
Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Alexander Egeberg,Joseph F. Merola,Knut Schäkel,Luis Puig,Patrick D. Mahar,Isabella Yali Wang,Imre Pavo,Christopher Schuster,Christopher E. M. Griffiths

DOI: https://doi.org/10.3389/fmed.2023.1171132

IF: 3.9

2023-03-10

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2022.1092688.].

medicine, general & internal
Corrigendum: Case report: An unusual case of desmin myopathy associated with heart failure and arrhythmia

Xuhan Liu,Yuan Liu,Bo Li,Lin Wang,Weihua Zhang

DOI: https://doi.org/10.3389/fcvm.2022.1002478

IF: 3.6

2022-10-03

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2022.944459.].

cardiac & cardiovascular systems
Corrigendum: Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review

Jianyu Zhu,Zhicheng Wang,Wenze Wang,Jinghua Fan,Yi Zhang,Xiaoxu Li,Jie Liu,Shenzhong Jiang,Kan Deng,Lian Duan,Yong Yao,Huijuan Zhu

DOI: https://doi.org/10.3389/fendo.2021.797828

IF: 6.055

2021-11-09

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2021.735655.].

endocrinology & metabolism
Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

DOI: https://doi.org/10.1177/24755303231195864

Abstract:[This corrects the article DOI: 10.1177/2475530320925067.].
Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

DOI: https://doi.org/10.1177/24755303231195862

Abstract:[This corrects the article DOI: 10.1177/2475530320970538.].
Corrigendum: Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot-Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection

Da Li,Hu Yu,Min Zhou,Weinv Fan,Qiongfeng Guan,Li Li

DOI: https://doi.org/10.3389/fneur.2024.1465995

2024-08-09

Abstract:[This corrects the article DOI: 10.3389/fneur.2024.1358881.].
Corrigendum: Case Report: A Chinese Family of Woodhouse-Sakati Syndrome With Diabetes Mellitus, With a Novel Biallelic Deletion Mutation of the DCAF17 Gene

Min Zhou,Ningjie Shi,Juan Zheng,Yang Chen,Siqi Wang,Kangli Xiao,Zhenhai Cui,Kangli Qiu,Feng Zhu,Huiqing Li

DOI: https://doi.org/10.3389/fendo.2022.856002

IF: 6.055

2022-02-21

Frontiers in Endocrinology

Abstract:[This corrects the article DOI: 10.3389/fendo.2021.770871.].

endocrinology & metabolism
Corrigendum to Tildrakizumab Inadequate Responders Switching to an Alternative IL-23 Inhibitor: A Case Series

DOI: https://doi.org/10.1177/24755303231195883

Abstract:[This corrects the article DOI: 10.1177/24755303211037308.].
Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Huimin Yan,Jia Lu,Jiabao Wang,Lu Chen,Yu Wang,Lin Li,Lin Miao,Han Zhang

DOI: https://doi.org/10.3389/fphar.2021.808424

IF: 5.6

2022-01-20

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.730567.].

pharmacology & pharmacy
Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

Tianwen Huang,Yaoyu Pu,Xiangpeng Wang,Yanhong Li,Hang Yang,Yubin Luo,Yi Liu

DOI: https://doi.org/10.3389/fmicb.2022.1100290

IF: 5.2

2022-12-12

Frontiers in Microbiology

Abstract:[This corrects the article DOI: 10.3389/fmicb.2022.965709.].

microbiology
Corrigendum to "The distinction of area postrema syndrome between MOGAD and NMOSD" [Heliyon 10(10) (May 2024) e30633]

Zhiming Zhou,Ying Chen,Jingzhi Zhangbao,Junfeng Xu,Chao Quan,Lei Zhou

DOI: https://doi.org/10.1016/j.heliyon.2024.e32900

IF: 3.776

2024-06-21

Heliyon

Abstract:[This corrects the article DOI: 10.1016/j.heliyon.2024.e30633.].
Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Quanfeng Zhao,Pan Ma,Peishu Fu,Jiayu Wang,Kejing Wang,Lin Chen,Yang Yang

DOI: https://doi.org/10.3389/fphar.2022.990048

IF: 5.6

2022-08-11

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2022.912256.].

pharmacology & pharmacy
Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

DOI: https://doi.org/10.1177/24755303231195863

Abstract:[This corrects the article DOI: 10.1177/2475530320970530.].
Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Tongshan Wang,Muyang Chen,Anpeng Wang,Hao Zhang

DOI: https://doi.org/10.3389/fimmu.2024.1530843

IF: 7.3

2024-12-03

Frontiers in Immunology

Abstract:This article is a correction to: Case Report: Long Remission and Survival Following Immunotherapy in a Case of Pulmonary Pleomorphic Carcinoma

immunology
Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

Xiao-sheng Hao,Jiang-tao Wang,Chen Chen,Yun-peng Hao,Jian-min Liang,Song-yan Liu

DOI: https://doi.org/10.3389/fneur.2023.1178132

IF: 3.4

2023-03-14

Frontiers in Neurology

Abstract:[This corrects the article DOI: 10.3389/fneur.2020.584446.].

neurosciences,clinical neurology
Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

Gianluca Mauri,Giorgio Patelli,Viviana Gori,Calogero Lauricella,Benedetta Mussolin,Alessio Amatu,Katia Bencardino,Federica Tosi,Erica Bonazzina,Emanuela Bonoldi,Alberto Bardelli,Salvatore Siena,Andrea Sartore-Bianchi

DOI: https://doi.org/10.3389/fonc.2023.1147497

IF: 4.7

2023-03-28

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1030232.].

oncology
Corrigendum to "Breast mucocele-like lesions (MLL): a case report and review of the literature". [ Radiol Case Rep 2024;19:1083-1089]

Assim Saad Eddin,Su Kim Hsieh,Fabiana Policeni

DOI: https://doi.org/10.1016/j.radcr.2024.06.036

2024-07-10

Abstract:[This corrects the article DOI: 10.1016/j.radcr.2023.12.017.].
Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations

Alasdair G. Kay,James M. Fox,James P. Hewitson,Andrew P. Stone,Sophie Robertson,Sally James,Xiao-nong Wang,Elizabeth Kapasa,Xuebin B. Yang,Paul G. Genever

DOI: https://doi.org/10.3389/fimmu.2022.1111042

IF: 7.3

2022-12-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.903796.].

immunology

Corrigendum: Case report: Challenges in the diagnosis of a case of Mal de Meleda and a therapeutic attempt of ixekizumab and Adalimumab

Correction: Corrigendum: Increased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective Study

Case Report: Challenges in the Diagnosis of a Case of Mal de Meleda and a Therapeutic Attempt of Ixekizumab and Adalimumab

Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Corrigendum: Case report: An unusual case of desmin myopathy associated with heart failure and arrhythmia

Corrigendum: Xanthomatous Hypophysitis: A Case Report and Comprehensive Literature Review

Corrigendum to Brodalumab for Treatment-Resistant Psoriasis: Case Reports and Safety Update

Corrigendum to Successful Treatment of Guttate Psoriasis With Ixekizumab: A Case Series

Corrigendum: Case report: Chronic inflammatory demyelinating polyneuropathy superimposed on Charcot-Marie-tooth type 1A disease after SARS-CoV-2 vaccination and COVID-19 infection

Corrigendum: Case Report: A Chinese Family of Woodhouse-Sakati Syndrome With Diabetes Mellitus, With a Novel Biallelic Deletion Mutation of the DCAF17 Gene

Corrigendum to Tildrakizumab Inadequate Responders Switching to an Alternative IL-23 Inhibitor: A Case Series

Corrigendum: Prevention of Cyclophosphamide-Induced Immunosuppression in Mice With Traditional Chinese Medicine Xuanfei Baidu Decoction

Corrigendum: Metabolomic analysis in spondyloarthritis: A systematic review

Corrigendum to "The distinction of area postrema syndrome between MOGAD and NMOSD" [Heliyon 10(10) (May 2024) e30633]

Corrigendum: Myelodysplastic syndrome/acute myeloid leukemia following the use of poly-ADP ribose polymerase inhibitors: A real-world analysis of postmarketing surveillance data

Corrigendum to A Case of Grover's Disease Secondary to Brodalumab Therapy for Psoriasis

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma

Corrigendum: Effectiveness of mycophenolate mofetil in the treatment of pediatric anti-NMDAR encephalitis: A retrospective analysis of 6 cases

Corrigendum: Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer

Corrigendum to "Breast mucocele-like lesions (MLL): a case report and review of the literature". [ Radiol Case Rep 2024;19:1083-1089]

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations